loteprednol synthesized ester loteprednol etabonate topical corticosteroid used treat inflammations eye marketed bausch lomb loterex patented approved medical use available generic applications drug include reduction inflammation eye seasonal allergic conjunctivitis chronic forms keratitis adenoviral thygesons keratitis vernal keratoconjunctivitispingueculitis giant papillary conjunctivitis contraindications corticosteroids immunosuppressive loteprednol contraindicated patients viral fungal mycobacterial infections common adverse effects patients treated gel formulation anterior chamber inflammation people eye pain foreign body sensation long term use days cause increased intraocular pressure loteprednol may interfere treatment glaucoma following ocular administration drug slowly absorbed blood therefore blood level limited extremely small concentration interactions drugs taken mouth route topical ophthalmic corticosteroids mediate antiinflammatory effects mainly modulation cytosolic glucocorticoid receptor gr genomic level preclinical studies demonstrated loteprednol etabonate highly lipophilic strong binding affinity glucocorticoid receptors binds gr cytoplasm activated corticosteroidgr complex migrates nucleus upregulates expression antiinflammatory proteins represses expression proinflammatory proteins corticosteroids inhibit inflammatory cytokines chemokines adhesion molecules inflammatory mediators also reduce synthesis histamine stabilize cell membranes inhibit degranulation mast cells recent work suggests activated corticosteroidgr complex also elicits nongenomic effects particularly inhibition vasodilation vascular permeability migration leukocytes neither loteprednol etabonate inactive metabolites acid acid etabonate detectable bloodstream even oral administration study patients receiving loteprednol eye drops days showed adrenal suppression would sign drug reaching bloodstream clinically relevant steroid receptor affinity times dexamethasone animal loteprednol etabonate developed using retrometabolic drug design socalled soft drug meaning structure designed predictably metabolised inactive substances metabolites acid etabonate derivatives cortienic acid inactive metabolite cortisol naturally occurring corticosteroid known hydrocortisone used drug acid inactive metabolite loteprednol cortienic acid inactive metabolite hydrocortisone loteprednol etabonate ester loteprednol etabonate ethyl carbonate pure chemical compound melting point solubility water therefore formulated ophthalmic use either ointment gel loteprednol corticosteroid ketone side chain classical corticosteroids hydrocortisone replaced cleavable ester accounts rapid etabonate ester httpsenwikipediaorgwikiloteprednol